安克生醫股份有限公司
安克生醫股份有限公司（AmCad BioMed Corporation）開發電腦輔助檢測與診斷（CAD）軟體。提供用於甲狀腺結節超音波檢測的「安克甲狀偵」、以及用於偵測呼吸中止症的「安克呼止偵」。目前正開發 AI 乳房病灶檢測方案。公司成立於 2008 年，總部位於台灣台北。
今日下跌 4.38%。該股 RSI(6) 為 51.7，處於中性區間，短線無明顯超買超賣訊號。股價站上5日、60日、120日均線，跌破20日均線。KD 指標中性（K=40.9）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 09-24 | -18 | 0 | +1 | -19 |
| 09-23 | +117 | 0 | +9 | +118 |
| 09-22 | -7 | 0 | +4 | -7 |
| 09-21 | +13 | 0 | +1 | +13 |
| 09-18 | -19 | 0 | 0 | -19 |
| 09-17 | 0 | 0 | +1 | 0 |
| 09-16 | +4 | 0 | +2 | +4 |
| 09-15 | -3 | 0 | +2 | -3 |
| 09-14 | -2 | 0 | +6 | -2 |
| 09-11 | -3 | 0 | +3 | -3 |
| 09-10 | -27 | 0 | +4 | -27 |
| 09-09 | +32 | 0 | 0 | +32 |
| 09-08 | -15 | 0 | +4 | -15 |
| 09-07 | +14 | 0 | +4 | +14 |
| 09-04 | +6 | 0 | 0 | +6 |
| 09-02 | -13 | 0 | 0 | -13 |
| 09-01 | -13 | 0 | 0 | -13 |
| 08-31 | -1 | 0 | 0 | -1 |
| 08-28 | +15 | 0 | +6 | +11 |
| 08-27 | 0 | 0 | +7 | +2 |
| 08-26 | +1 | 0 | +2 | 0 |
| 08-25 | 0 | 0 | +4 | +2 |
| 08-24 | +2 | 0 | +2 | +3 |
| 08-21 | +3 | 0 | 0 | +3 |
| 08-20 | 0 | 0 | 0 | 0 |
| 08-19 | -3 | 0 | 0 | -3 |
| 08-18 | 0 | 0 | 0 | 0 |
| 08-17 | -3 | 0 | 0 | -3 |
| 08-14 | +4 | 0 | 0 | +4 |
| 08-13 | +2 | 0 | +2 | +3 |
| 08-12 | 0 | 0 | 0 | 0 |
| 08-10 | -3 | 0 | 0 | -3 |
| 08-07 | -2 | 0 | 0 | -2 |
| 08-06 | 0 | 0 | 0 | 0 |
| 08-05 | +5 | 0 | 0 | +5 |
| 08-04 | +3 | 0 | 0 | +3 |
| 08-03 | +2 | 0 | 0 | +2 |
| 07-31 | -3 | 0 | 0 | -3 |
| 07-30 | 0 | 0 | 0 | 0 |
| 07-29 | -3 | 0 | +2 | -4 |
| 07-28 | -2 | 0 | +4 | -2 |
| 07-27 | -2 | 0 | 0 | -2 |
| 07-24 | -5 | 0 | +2 | -4 |
| 07-23 | +2 | 0 | 0 | +2 |
| 07-22 | +2 | 0 | 0 | +2 |
| 07-20 | -4 | 0 | 0 | -4 |
| 07-16 | 0 | 0 | 0 | 0 |
| 07-15 | 0 | 0 | +2 | 0 |
| 07-14 | -3 | 0 | 0 | -3 |
| 07-13 | 0 | 0 | 0 | 0 |
| 07-09 | +11 | 0 | 0 | +11 |
| 07-07 | -4 | 0 | 0 | -4 |
| 07-06 | -7 | 0 | 0 | -7 |
| 07-03 | +9 | 0 | 0 | +9 |
| 07-02 | +2 | 0 | 0 | +2 |
| 07-01 | 0 | 0 | +2 | 0 |
| 06-30 | +6 | 0 | 0 | +6 |
| 06-29 | -2 | 0 | 0 | -2 |
| 06-26 | -8 | 0 | 0 | -8 |
| 06-25 | +8 | 0 | 0 | +8 |
| 06-23 | -2 | 0 | 0 | -2 |
| 06-18 | +15 | 0 | 0 | +15 |
| 06-17 | +4 | 0 | 0 | +4 |
| 06-16 | -4 | 0 | 0 | -4 |
| 06-12 | -14 | 0 | 0 | -14 |
| 06-11 | -6 | 0 | 0 | -6 |
| 06-10 | -4 | 0 | 0 | -4 |
| 06-08 | +4 | 0 | 0 | +4 |
| 06-05 | -3 | 0 | 0 | -3 |
| 06-04 | +6 | 0 | 0 | +6 |
| 06-03 | +5 | 0 | 0 | +5 |
| 06-02 | -6 | 0 | 0 | -6 |
| 06-01 | +13 | 0 | 0 | +13 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/04 | 268 萬 | +39.8% | -3.0% |
| 2026/03 | 192 萬 | +23.7% | -13.1% |
| 2026/02 | 155 萬 | -46.7% | -31.6% |
| 2026/01 | 291 萬 | +138.1% | +26.5% |
| 2025/12 | 122 萬 | -6.3% | -84.3% |
| 2025/11 | 131 萬 | -48.5% | -81.1% |
| 2025/10 | 254 萬 | -57.5% | -25.6% |
| 2025/09 | 597 萬 | +156.0% | +73.9% |
| 2025/08 | 233 萬 | +9.4% | -7.5% |
| 2025/07 | 213 萬 | -28.9% | -53.3% |
| 2025/06 | 300 萬 | +25.4% | -50.1% |
| 2025/05 | 239 萬 | - | -67.4% |